Last reviewed · How we verify
NCT06097585
Gliflozins on HF in Regurgitant Rheumatic Heart
trial testing SGLT2 inhibitor in Rheumatic Heart Disease in 150 participants. Status unknown.
1 December 2024
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 1 December 2023 |
| Primary completion | 1 December 2024 |
| Estimated completion | 1 April 2025 |
Drugs / interventions tested
- SGLT2 inhibitor — full drug profile →
Conditions studied
- Rheumatic Heart Disease — all drugs for Rheumatic Heart Disease →
- Heart Failure — all drugs for Heart Failure →
Sponsor
Assiut University
Who can join
18 and older, any sex, with Rheumatic Heart Disease or Heart Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this trial is to detect impact of Gliflozin on patients with heart failure due to reurgitant rheumatic valve disease
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
SGLT2 Inhibition as a Novel Therapeutic Strategy in Rheumatic Heart Disease
Morel O, Mai A, Zühlke L, Jouven X, et al · · 2026
Verify or expand the search:
- PubMed search for NCT06097585
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of SGLT2 inhibitor
Trials testing the same drug.
- NCT07360457 — GLP1 Analogues and the Risk of Osteoarthritis · not yet recruiting
- NCT07172971 — Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy · Phase 1 · not yet recruiting
- NCT07334145 — Effect of SGLT2 Inhibitors on Anemic CKD Patients · not yet recruiting
- NCT07063316 — SGLT2 Inhibitors and Renal Anemia in Japan: RWD · active not recruiting
- NCT06350487 — The Efficacy of Enavogliflozin in Heart Failure With Preserved Ejection Fraction · Phase 4 · not yet recruiting
Other recruiting trials for Rheumatic Heart Disease
Currently open trials in the same condition.
- NCT06952374 — Treating Severe Mitral Valve Annular or Valvular Calcification Using Shockwave Balloon SMARTWAVE · NA · recruiting
- NCT05783375 — Accelerating Delivery of rheUmatic Heart Disease Preventive iNterventions in Northern Uganda · NA · recruiting
- NCT05693545 — GOALIE: Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent RHD Trial · Phase 2 · active not recruiting
- NCT05991219 — Screening and Secondary Prevention Rheumatic Heart Disease Study · recruiting
- NCT05504928 — Effectiveness of a School-centered Prevention Program on Prevalence of Latent Rheumatic Heart Disease · NA · recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06097585 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 30 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06097585.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing